Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
about
Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developmentsImmunomodulation in sepsis: state of the art and future perspectiveSepsis and Acute Respiratory Distress Syndrome: Recent UpdateDetrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapiesImmunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridgeClinical review: use of renal replacement therapies in special groups of ICU patientsNovel formulations for antimicrobial peptidesTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectRenal replacement therapy in acute kidney injury: controversy and consensusNomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications.Successful treatments with polymyxin B hemoperfusion and recombinant human thrombomodulin for fulminant Clostridium difficile-associated colitis with septic shock and disseminated intravascular coagulation: a case reportAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-AnalysisEffects of paracentesis on hemodynamic parameters and respiratory function in critically ill patientsTherapeutic effect of direct hemoperfusion with a polymyxin B-immobilized fiber column in the treatment of HIV-negative severe pneumocystis pneumonia.Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study.The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis.Fenoldopam use in a burn intensive care unit: a retrospective study.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceA Pilot Randomized Controlled Trial of Comparison between Extended Daily Hemodialysis and Continuous Veno-venous Hemodialysis in Patients of Acute Kidney Injury with Septic Shock.Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients.A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotypeIntensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shockEfficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.Blood purification and mortality in sepsis: a meta-analysis of randomized trialsSupplemental Cardioplegia Immediately before Graft Implantation may Improve Early Post-Transplantation OutcomeEndothelium dependent vasomotion and in vitro markers of endothelial repair in patients with severe sepsis: an observational study.Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema StudyThe Japanese guidelines for the management of sepsis.Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure: a retrospective case series.Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock.Clinical review: blood purification for sepsis.What blood temperature for an ex vivo extracorporeal circuit?Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.Polymyxin-B-immobilized-fiber column hemoperfusion with oseltamivir treatment for ARDS due to influenza H1N1/09Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
P2860
Q21195747-91A696AD-2E88-47AE-A732-41CF76C0A7D2Q22305766-D3B9068E-172E-4744-A932-7BE9D16673D7Q26749485-9699C980-6E40-4572-A4B1-59122EA9DDA2Q26765788-4AB63ECA-F456-4B2F-877B-1DF3C8DA48C6Q26830445-F1DED229-9BA5-4E1F-B166-DCE222D2C3C5Q26853350-1BD78D38-610A-4C7B-91F1-DD0F4F3A2CE1Q26991771-2E0914A6-B01A-4FF4-81F2-12B1EE59ABF6Q26996658-AEC2D267-44C6-4136-9898-BEF4F390758CQ26998864-E20D3021-B19B-4B2E-B947-6FD264BBCD78Q28070353-D102BAAE-79DE-445F-9F6C-F50921C2643FQ28828482-F2DA8BCE-CA51-4F9F-8ABA-4C4A88B78C05Q30234560-A8EF5536-A764-4A6D-89A0-A9CFA08D4F66Q30234954-FADE0CDA-C9D8-43A8-8D82-316CEE3B7818Q30491514-4E8A2039-DF6C-41E2-AB46-C27D2F8C6A8EQ31148915-1E4BC4FD-C75A-4285-BBF6-92E2CEDF643DQ33389994-B08D93AE-5113-43AC-93A7-F75904FD6157Q33519766-0F961C64-A44D-4EAC-9304-B4D2BAD7C0B2Q33604079-B82270D1-0443-49EB-872C-D26DE2F51F03Q33615400-2EEFCF17-C2F4-4565-AE1F-8D931193A15EQ33640559-BC597CA8-3D60-4F9C-82F1-3DCF84D32C26Q33755514-269592D3-FEE2-4755-84C1-FB47B90FD664Q33776933-00CF64EC-8123-4460-938E-2465051110E4Q33923951-5C2B32AD-0548-445B-9C1B-A20867AA7050Q34305100-2E0723E1-6A49-420A-93B9-FB2987DDC96FQ34697264-33B37576-3479-4E5E-A0BF-D5D94D468EABQ34771631-8C30F37E-8C72-478D-8BAB-2BFBE564ABC6Q34824051-69279A81-B8B7-4724-BF5D-B5261634535FQ34867814-095FC3B9-640B-4254-92EC-384EEDB5617BQ34924412-4A48515E-6AB4-488A-B707-5D938D788B92Q35091191-A3B6A9BE-E22A-4B85-98E9-323DA436F13FQ35107091-00BB5AAE-8B99-4CA9-AA28-900B5EB71634Q35107094-EBDC782E-F066-4CFE-B164-F3D78F8DA3CAQ35176933-D46FCAA3-E133-4551-821C-2FFF5172DE78Q35358796-04C13A4A-F57C-46BB-B06C-1379CE336E2CQ35567169-0FD72557-3FD4-4A47-8226-A18820F94FBCQ35575149-CC983209-8487-477C-B098-6D804B72C314Q35686356-DAF5B785-A13C-4B8E-8635-D56DD5024D5EQ35747336-3C4ED909-4514-4CBB-8D62-1BA943BC0BC4Q35761448-93DF8143-F375-40BB-B3F3-671C1FB4FF9FQ35770922-5A2B6D6E-802B-4335-8EA5-8493614C0F06
P2860
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Early use of polymyxin B hemop ...... S randomized controlled trial.
@en
type
label
Early use of polymyxin B hemop ...... S randomized controlled trial.
@en
prefLabel
Early use of polymyxin B hemop ...... S randomized controlled trial.
@en
P2093
P356
P1476
Early use of polymyxin B hemop ...... S randomized controlled trial.
@en
P2093
Dinna N Cruz
Federica Rottoli
Flavia Petrini
Francesca Foltran
Francesco Giunta
Franco M Bobbio Pallavicini
Giada Volta
Massimo Antonelli
Nicola Brienza
Roberto Fumagalli
P304
P356
10.1001/JAMA.2009.856
P407
P577
2009-06-01T00:00:00Z